Diagnosis of pulmonary tuberculosis among asymptomatic HIV + patients in Guangxi, China

Chinese Medical Journal

Volumn 123, Issue 23, 2010, Pages 3400-3405

  Zhang, Yao ^a   Yu, Lan ^a   Tang, Zhi Rong ^c   Huang, Shao Biao ^d   Zheng, Yuan Jia ^e   Meng, Zhi Hao ^f   Sun, Kai ^g,h   Wang, Li Ming ⁱ   Chen, Ray Y ^j   Zhang, Fu Jie ^a,b  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c Provincial Center of Diseases Control and Prevention   (China)

^d Nanning 4th People's Hospital   (China)

^e Center for Diseases Control and Prevention of Liuzhou City   (China)

^f Liuzhou Longtan Hospital   (China)

^g UNIVERSITY OF NORTH CAROLINA   (United States)

^h WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^j NATIONAL INSTITUTES OF HEALTH   (United States)

more..

Author keywords

Diagnosis; Human immunodeficiency virus; Tuberculosis

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; BODY MASS; CD4 LYMPHOCYTE COUNT; CHINA; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; LUNG TUBERCULOSIS; LYMPHADENOPATHY; PHYSICAL EXAMINATION; PREVALENCE; PROGNOSIS; SCREENING; SENSITIVITY AND SPECIFICITY; SPUTUM CULTURE; SPUTUM SMEAR; THORAX RADIOGRAPHY; TUBERCULOUS LYMPHADENITIS;

ADULT; CHINA; FEMALE; HIV SEROPOSITIVITY; HUMANS; LOGISTIC MODELS; LYMPHATIC DISEASES; MALE; MIDDLE AGED; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SPUTUM; TUBERCULOSIS, PULMONARY;

EID: 78649850385     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2010.23.005     Document Type: Article

References (33)

1. Yew WW, Leung CC. Update in tuberculosis 2006. Am J Respir Crit Care Med 2007; 131: 1133-1141.
2. Jiang W, Shao L, Zhang Y, Zhang S, Meng C, Xu Y, et al. High-sensitive and rapid detection of Mycobacterium tuberculosis infection by IFN-gamma release assay among HIV-infected individuals in BCG-vaccinated area. BMC Immunol 2009; 10: 31.
3. Yu L, Wang L, Tang ZR, Huang SB, Meng ZH, Zhou P, et al. The diagnosis and method investigation of active tuberculosis situation among HIV/AIDS patients. Chin J Lab Med (Chin) 2009; 32: 377-382.
4. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 1999; 282: 677-686.
5. Zhou J, Elliott J, Li PC, Lim PL, Kiertiburanakul S, Kumarasamy N, et al. Risk and prognostic significance of tuberculosis in patients from The TREAT Asia HIV Observational Database. BMC Infect Dis 2009; 9: 46.
6. Reid MJ, Shah NS. Approaches to tuberculosis screening and diagnosis in people with HIV in resource-limited settings. Lancet Infect Dis 2009; 9: 173-184.
7. Day JH, Charalambous S, Fielding KL, Hayes RJ, Churchyard GJ, Grant AD. Screening for tuberculosis prior to isoniazid preventive therapy among HIV-infected gold miners in South Africa. Int J Tuberc Lung Dis 2006; 10: 523-529.
8. Mtei L, Matee M, Herfort O, Bakari M, Horsburgh CR, Waddell R, et al. High rates of clinical and subclinical tuberculosis among HIV-infected ambulatory subjects in Tanzania. Clin Infect Dis 2005; 40: 1500-1507.
9. Swaminathan S, Paramasivan CN, Kumar SR, Mohan V, Venkatesan P. Unrecognized tuberculosis in HIV-infected patients: sputum culture is a useful tool. Int J Tuberc Lung Dis 2004; 8: 896-898.
10. TB/HIV a clinical manual. Geneva: World Health Organization, 2004. (Accessed March 19, 2010 at http://www.who.int/tb/publications/who_htm_tb_2004_329/en/index.html)
11. Bassett L, Chetty B, Wang B, Giddy J, Losina E, Mazibuko Allen MJ, et al. Intensive TB screening for HIV-infected patients ready to start ART in Durban, South Africa: limitations of WHO guidelines. 16th Conference on Retroviruses and Opportunistic Infections, Montreal, Canada, 2010.
12. Cain KP, McCarthy KD, Heilig CM, Monkongdee P, Tasaneeyapan T, Kanara N, et al. An algorithm for tuberculosis screening and diagnosis in people with HIV. N Engl J Med 2010; 362: 707-716.
13. Kaplan JE, Benson C, Holmes KH, Brooks JT, Pau A, Masur H. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2009; 58(RR-4): 1-207.
14. China free ART manual. Beijing: Chinese Center for Disease Control and Prevention, 2007. (Accessed August 8, 2009 at http://www.chinaids.org.cn/n16/n1657/32880.html)
15. Palmieri F, Girardi E, Pellicelli AM, Rianda A, Bordi E, Rizzi EB, et al. Pulmonary tuberculosis in HIV-infected patients presenting with normal chest radiograph and negative sputum smear. Infection 2002; 30: 68-74.
16. Meintjes G, Lawn SD, Scano F, Maartens G, French MA, Worodria W, et al. Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis 2008; 8: 516-523.
17. Bulterys M, Vermund SH, Chen RY, Ou CY. A public health approach to rapid scale-up of free antiretroviral treatment in China: an ounce of prevention is worth a pound of cure. Chin Med J 2009; 122: 1352-1355.
18. Post FA, Wood R, Pillay GP. Pulmonary tuberculosis in HIV infection: radiographic appearance is related to CD4+ T-lymphocyte count. Tuber Lung Dis 1995; 76: 518-521.
19. Perlman DC, el-Sadr WM, Nelson ET, Matts JP, Telzak EE, Salomon N, et al. Variation of chest radiographic patterns in pulmonary tuberculosis by degree of human immuno- deficiency virus-related immunosuppression. The Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). The AIDS Clinical Trials Group (ACTG). Clin Infect Dis 1997; 25: 242-246.
20. Girardi E, Sabin CA, d'Arminio Monforte A, Hogg B, Phillips AN, Gill MJ, et al. Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America. Clin Infect Dis 2005; 41: 1772-1782.
21. Jones JL, Hanson DL, Dworkin MS, Kaplan JE, Ward JW. Trends in AIDS-related opportunistic infections among men who have sex with men and among injecting drug users, 1991-1996. J Infect Dis 1998; 178: 114-120.
22. Podlekareva D, Mocroft A, Dragsted UB, Ledergerber B, Beniowski M, Lazzarin A, et al. Factors associated with the development of opportunistic infections in HIV-1-infected adults with high CD4+ cell counts: a EuroSIDA study. J Infect Dis 2006; 194: 633-641.
23. Dembele M, Saleri N, Carvalho AC, Saouadogo T, Hien AD, Zabsonre I, et al. Incidence of tuberculosis after HAART initiation in a cohort of HIV-positive patients in Burkina Faso. Int J Tuberc Lung Dis 2010; 14: 318-323.
24. Castilla J, Gutierrez A, Guerra L, Perez de la Paz J, Noguer I, Ruiz C, et al. Pulmonary and extrapulmonary tuberculosis at AIDS diagnosis in Spain: epidemiological differences and implications for control. AIDS 1997; 11: 1583-1588.
25. Wilson D, Nachega JB, Chaisson RE, Maartens G. Diagnostic yield of peripheral lymph node needle-core biopsies in HIV-infected adults with suspected smear-negative tuberculosis. Int J Tuberc Lung Dis 2005; 9: 220-222.
26. Mohan A, Reddy MK, Phaneendra BV, Chandra A. A etiology of peripheral lymphadenopathy in adults: analysis of 1724 cases seen at a tertiary care teaching hospital in southern India. Natl Med J India 2007; 20: 78-80.
27. Sungkanuparph S, Eampokalap B, Chottanapund S, Thongyen S, Manosuthi W. Impact of drug-resistant tuberculosis on the survival of HIV-infected patients. Int J Tuberc Lung Dis 2007; 11: 325-330.
28. Varma JK, Nateniyom S, Akksilp S, Mankatittham W, Sirinak C, Sattayawuthipong W, et al. HIV care and treatment factors associated with improved survival during TB treatment in Thailand: an observational study. BMC Infect Dis 2009; 9: 42.
29. Domingos MP, Caiaffa WT, Colosimo EA. Mortality, TB/HIV co-infection, and treatment dropout: predictors of tuberculosis prognosis in Recife, Pernambuco State, Brazil. Cad Saude Publica 2008; 24: 887-896.
30. Manosuthi W, Chottanapand S, Thongyen S, Chaovavanich A, Sungkanuparph S. Survival rate and risk factors of mortality among HIV/tuberculosis-coinfected patients with and without antiretroviral therapy. J Acquir Immune Defic Syndr 2006; 43: 42-46.
31. Sanguanwongse N, Cain KP, Suriya P, Nateniyom S, Yamada N, Wattanaamornkiat W, et al. Antiretroviral therapy for HIV-infected tuberculosis patients saves lives but needs to be used more frequently in Thailand. J Acquir Immune Defic Syndr 2008; 48: 181-189.
32. Whalen CC, Johnson JL, Okwera A, Hom DL, Huebner R, Mugyenyi P, et al. A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration. N Engl J Med 1997; 337: 801-808.
33. Soumya Swaminathan PM, Perumal V, Santhanakrishnan RK, Ramachandran R, Chinnaiah P, Iliayas S, et al. Efficacy of a 6-month vs. a 36-month regimen for prevention of tuberculosis in HIV-infected persons in India: a randomized clinical trial. 17th Conference on Retroviruses and Opportunistic Infections, San Francisco, USA, 2010.